These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 25658232

  • 1. [Castration resistant prostate cancer 2015].
    Merseburger AS, Böker A, Kuczyk MA, von Klot CA.
    Aktuelle Urol; 2015 Jan; 46(1):59-65. PubMed ID: 25658232
    [Abstract] [Full Text] [Related]

  • 2. Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review.
    Cursano MC, Iuliani M, Casadei C, Stellato M, Tonini G, Paganelli G, Santini D, De Giorgi U.
    Crit Rev Oncol Hematol; 2020 Feb; 146():102864. PubMed ID: 31986318
    [Abstract] [Full Text] [Related]

  • 3. Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker.
    Heinrich D, Bruland Ø, Guise TA, Suzuki H, Sartor O.
    Future Oncol; 2018 Oct; 14(24):2543-2556. PubMed ID: 29925281
    [Abstract] [Full Text] [Related]

  • 4. Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.
    Nuhn P, De Bono JS, Fizazi K, Freedland SJ, Grilli M, Kantoff PW, Sonpavde G, Sternberg CN, Yegnasubramanian S, Antonarakis ES.
    Eur Urol; 2019 Jan; 75(1):88-99. PubMed ID: 29673712
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer.
    Ueda Y, Matsubara N, Takizawa I, Nishiyama T, Tabata K, Satoh T, Kamiya N, Suzuki H, Kawahara T, Uemura H.
    Jpn J Clin Oncol; 2015 Aug; 45(8):774-9. PubMed ID: 25981621
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer.
    Picciotto M, Franchina T, Russo A, Ricciardi GRR, Provazza G, Sava S, Baldari S, Caffo O, Adamo V.
    Expert Opin Pharmacother; 2017 Jun; 18(9):899-908. PubMed ID: 28449621
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Current therapeutic options in metastatic castration-resistant prostate cancer.
    Ingrosso G, Detti B, Scartoni D, Lancia A, Giacomelli I, Baki M, Carta G, Livi L, Santoni R.
    Semin Oncol; 2018 Oct; 45(5-6):303-315. PubMed ID: 30446166
    [Abstract] [Full Text] [Related]

  • 12. Sequencing Treatment for Castration-Resistant Prostate Cancer.
    Handy CE, Antonarakis ES.
    Curr Treat Options Oncol; 2016 Dec; 17(12):64. PubMed ID: 27822685
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
    de Bono JS, Smith MR, Saad F, Rathkopf DE, Mulders PFA, Small EJ, Shore ND, Fizazi K, De Porre P, Kheoh T, Li J, Todd MB, Ryan CJ, Flaig TW.
    Eur Urol; 2017 Apr; 71(4):656-664. PubMed ID: 27402060
    [Abstract] [Full Text] [Related]

  • 17. Prostate-Specific Antigen Flare Phenomenon During 223Ra-Dichloride Treatment for Bone Metastatic Castration-Resistant Prostate Cancer: A Case Report.
    De Vincentis G, Follacchio GA, Frantellizzi V, Liberatore M, Monteleone F, Cortesi E.
    Clin Genitourin Cancer; 2016 Oct; 14(5):e529-e533. PubMed ID: 27212044
    [No Abstract] [Full Text] [Related]

  • 18. Metastatic castration-resistant prostate cancer: integrating new learnings to optimise treatment outcomes.
    Heidenreich A, Porres D, Piper C, Thissen AK, Pfister D.
    Minerva Urol Nefrol; 2013 Sep; 65(3):171-87. PubMed ID: 23872628
    [Abstract] [Full Text] [Related]

  • 19. Current treatment strategies for advanced prostate cancer.
    Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW.
    Int J Urol; 2018 Mar; 25(3):220-231. PubMed ID: 29266472
    [Abstract] [Full Text] [Related]

  • 20. [Biomarkers in metastatic castration-resistant prostate cancer].
    Miller K.
    Aktuelle Urol; 2015 Jan; 46(1):66-70. PubMed ID: 25658233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.